# Worldwide Clinical Trials Holdings

Worldwide Clinical Trials Holdings is an Asset Manager based in United States, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** United States, United States
- **Region:** North America
- **Address:** United States
- **Assets under management:** Undisclosed
- **Website:** www.worldwide.com

## Regulatory record

- **Reports private funds:** No

## About

Worldwide Clinical Trials is a top-rated, full-service global CRO. We provide 30+ years of clinical expertise to benefit your study. Learn more about us here.

## Sectors

- Healthcare Services
- Digital Health
- AI/ML

## People

- Alistair Macdonald — Chief Executive Officer
- Michael Murphy — Chief Medical and Scientific Officer
- Lona Sheeran — Senior Vice President, Clinical Operations Early Phase

## Questions

### Who runs investment decisions at Worldwide Clinical Trials Holdings?

Investment decisions are led by CEO Alistair Macdonald, appointed in 2026 (per firm press release, 2026). Dr. Michael Murphy serves as Chief Medical and Scientific Officer, overseeing therapeutic strategy. The firm does not disclose a formal investment committee or external GP relationships.

### How does Worldwide Clinical Trials source proprietary deal flow?

The firm originates business through clinical trial service contracts with pharmaceutical and biotechnology companies. Its deal flow is driven by therapeutic expertise and relationships with drug developers, rather than through traditional investment sourcing channels like fund commitments or co-investments.

### What investment stages does Worldwide Clinical Trials typically target?

The firm supports clinical development across all phases — from early-phase through late-stage trials. Its services are tailored to therapeutic areas such as oncology, neuroscience, rare disease, and cell and gene therapy. Specific stage preferences or fund structures are not publicly available.

### What is Worldwide Clinical Trials' known posture on co-investments alongside external GPs?

Worldwide Clinical Trials does not appear to participate in co-investments alongside external GPs. Its business model is service-oriented, providing clinical trial management rather than direct investment. No co-investment activity has been publicly reported.

## Related profiles

- [Harvey Industries](https://altss.com/profile/harvey-industries)
- [MFG Chemical](https://altss.com/profile/mfg-chemical)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/worldwide-clinical-trials-holdings

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology